RPGLIFENSERPG LIFE SCIENCES LTD· Pharmaceuticals & BiotechnologyHighNeutral
Announced Thu, 29 Oct, 2026 · 22:03 IST

Q2 FY27 consolidated revenue rises 16.5%, but owners' profit falls 28%

Ebitda Margin CompressionExceptional ItemResults View source PDFExplain this filing

RPGLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-15.4%Reaction day
₹3009.00
prior close
₹2812.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending
Pharmaceuticals peers, median of 173sector-0.8%-14.6% vs sector

On the reaction day the stock moved 14.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.6
10m
+0.3
15m
+0.2
30m
-1.9
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-15.4pendingpending-0.8-14.6
Next day
—————
2d
—————
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Consolidated quarterly revenue was Rs 21,164 lakh, up 16.5% year on year, while pre-tax profit excluding one-off items fell 3.2% to Rs 3,704 lakh. Owners' profit fell 27.8% to Rs 2,660 lakh; the prior-year quarter included a Rs 1,122 lakh fire insurance gain. For the six months, revenue rose 16.2% to Rs 40,733 lakh and owners' profit fell 9.5% to Rs 5,717 lakh. Standalone operating cash inflow was Rs 2,308 lakh. Acquisitions limit comparisons.

Likely market impact

Revenue growth is encouraging, but profit weakened. A prior-year one-off gain and new acquisitions affect comparisons, so focus on underlying earnings.